 Zee News | GlaxoSmithKline Pharma Q4 Net inches up Zee News Altargo was launched in the dermatology portfolio, Volibris was launched to treat pulmonary arterial hypertension (PAH) and Hycamtin was launched to fulfil unmet needs for patients with advance cancers and relapsed small cell lung cancer, it added. GlaxoSmithKline Pharmaceuticals Net Sales up 16%, PAT before Exceptional ... |
